PolyPeptide Group Ltd.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About PolyPeptide Group Ltd.
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy PolyPeptide Group Ltd. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for PolyPeptide Group Ltd. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for PolyPeptide Group Ltd. is PPGN:xswx. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
PolyPeptide Group Ltd. has its primary listing on SIX Swiss Exchange. You can trade PolyPeptide Group Ltd. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, PolyPeptide Group Ltd. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include PolyPeptide Group Ltd. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like PolyPeptide Group Ltd..